Hi-Fatigue G Bone Cement Retrospective Study
- Conditions
- Total Hip and Knee Arthroplasties
- Registration Number
- NCT06699134
- Lead Sponsor
- Zimmer Biomet
- Brief Summary
The objective of this retrospective monocentric study is to collect survivorship and clinical data confirming safety, performance and clinical benefits for the Hi-Fatigue G Bone Cement.
The assessments will include:
* Radiological analysis performed at different time points according to the standard of care of the hospital
* Implant survivorship and safety based on removal of a study device
* Patient reported outcome measures (PROMs)
Primary endpoint:
Assessment of radiolucent lines around the components (tibial, femoral, acetabular) at 5 years (in accordance with the hospital standard of care).
Secondary endpoints:
* Evaluation of implant survivorship and safety by monitoring the frequency and incidence of adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.
* Evaluation of PROMs
* Obtain information regarding the cementing technique and handling of the cement, if available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 90
- Subject qualified for cemented TKA or THA with a Zimmer Biomet implant
- Subject is willing and able to give written informed consent for retrospective data collection and undergo interim and final evaluation (X-Ray & Scores completion)
- Subject > 18 years old
- Muscle wasting
- Neuromuscular compromise in the affected limb
- Known hypersensitivity to any of the cement constituents
- Subjects with severe renal failure
- Bilateral interventions
- Subject is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, known alcohol or drug abuser, anticipated to be non-compliant)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Radiographic evaluation From enrollment to the 5 year post-op follow up. Detection of radiolucent lines around the implant components (tibial, femoral, acetabular) at 5 years (in accordance with the hospital standard of care).
- Secondary Outcome Measures
Name Time Method Survivorship From enrollment to the 5 year post-op follow up. Evaluation of implant survivorship and safety by monitoring the frequency and incidence of adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.
Patient reported outcome measures (PROM) From enrollment to the 5 year post-op follow up. Evaluation of PROMs, collected in accordance with the hospital standard of care.
Cement Information From enrollment to the 5 year post-op follow up. Obtain information regarding the cementing technique and handling of the cement, if available
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Klinikum Weiden
🇩🇪Weiden, Bavaria, Germany